Crossmark

A comprehensive systematic review and meta-analysis of ensifentrine in COPD: dose-dependent effects, safety profile, and GRADE-based certainty of evidence

Crossref DOI link: https://doi.org/10.1007/s00210-025-04558-1

Published Online: 2025-09-11

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abou Elezz, Amr M. https://orcid.org/0009-0004-8806-2624
Khalefa, Kareem

Gadelmawla, Ahmed Farid https://orcid.org/0000-0002-5802-2291
Taman, Lamees

Saeed, Habiba Tariq

Elkelany, Amr Alaa Azzouz

Elrefaey, Habiba Abdelhameed

Abo Zeid, Mohamed
Funding

Funding for this research was provided by:

Tanta University
License Information

Text and Data Mining valid from 2025-09-11

Version of Record valid from 2025-09-11
More Information

Article History

Received: 28 June 2025

Accepted: 14 August 2025

First Online: 11 September 2025

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below